Abstract: Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles and 1H-1,2,4-triazoles wherein the 1,3-dioxolane ring is substituted in the 4- and in the 5-positions, said compounds having useful antimicrobial properties.
Type:
Grant
Filed:
November 7, 1983
Date of Patent:
July 22, 1986
Assignee:
Janssen Pharmaceutica, N.V.
Inventors:
Jan Heeres, Leo Backx, Willy Van Laerhoven, Elmar Sturm
Abstract: Novel N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives having antihistaminic properties which compounds are useful in the treatment of allergic diseases.
Type:
Grant
Filed:
October 15, 1984
Date of Patent:
May 13, 1986
Assignee:
Janssen Pharmaceutica N.V.
Inventors:
Frans E. Janssens, Joseph L. G. Torremans, Jozef F. Hens, Theophilus T. J. M. Van Offenwert
Abstract: A synthetic peptide which possesses the ability to specifically induce the differentiation of precursor B cells into mature B-cells capable of producing antibody.
Type:
Grant
Filed:
January 31, 1985
Date of Patent:
April 22, 1986
Assignee:
Ortho Pharmaceutical Corporation
Inventors:
Tapan Audhya, Daniel J. Kroon, George Heavner, Gideon Goldstein
Abstract: Process of aiding regression and palliation of neoplastic disease in animal and human hosts comprising systemic administration to phenylimidazo[2,1-b]thiazole or a nontoxic acid addition salt thereof. Preferably the active ingredient is administered in a sufficient amount to provide dosages over the range from about 1 mg to about 5 mg/kg of body weight of the host.
Type:
Grant
Filed:
February 2, 1981
Date of Patent:
April 22, 1986
Assignee:
Janssen Pharmaceutica N.V.
Inventors:
Josephus Brugmans, William Pollack, Paul A. J. Janssen, Daniel Tripodi
Abstract: Novel [[bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones, wherein the pyrimidinone-ring is embraced within a bicyclic system, being useful compounds in the treatment of psychosomatic disorders.
Type:
Grant
Filed:
September 27, 1984
Date of Patent:
April 8, 1986
Assignee:
Janssen Pharmaceutica, N.V.
Inventors:
Ludo E. J. Kennis, Jan Vandenberk, Josephus C. Mertens
Abstract: Novel N-(bicyclic heterocyclyl)-4-piperidinamines having antihistaminic and serotonin-antagonistic properties which are useful in the treatment of allergic diseases.
Type:
Grant
Filed:
April 22, 1983
Date of Patent:
December 3, 1985
Assignee:
Janssen Pharmaceutica N.V.
Inventors:
Frans E. Janssens, Joseph L. G. Torremans, Jozef F. Hens, Theophilus T. J. M. Van Offenwert
Abstract: Novel 5H-thiazolo- and 5H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one and 3,4-dihydro-2H,6H-pyrimido[2,1-b] [1,3]-thiazin-6-one derivatives, which compounds are useful psychotropic agents.
Abstract: Immunoregulating peptides are disclosed which are cyclic peptides similar to thymopentin. These peptides are useful for their effects on the immune system, especially the treatment of thymic deficiencies.
Type:
Grant
Filed:
June 11, 1984
Date of Patent:
October 15, 1985
Assignee:
Ortho Pharmaceutical Corporation
Inventors:
Gideon Goldstein, George Heavner, Tapan Audhya, Foe-Siong Tjoeng
Abstract: The agents protect wood and coatings against deterioration by microorganisms. The agents contain at least one compound of the formula ##STR1## wherein X is nitrogen or a CH group and R.sub.1 is a radical of the formula ##STR2## wherein Ar, R and Z are as defined in claim 1, or an acid addition salt thereof.
Type:
Grant
Filed:
November 2, 1983
Date of Patent:
September 17, 1985
Assignee:
Janssen Pharmaceutica N.V.
Inventors:
Josef Van Gestel, Benedikt Duytschaever, Rene Muntwyler, Max Scharer
Abstract: 1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles having anticonvulsant properties which are particularly useful in the treatment of generalized forms of epilepsy.
Abstract: Novel [[bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones, wherein the pyrimidinone-ring is embraced within a bicyclic system, being useful compounds in the treatment of psychosomatic disorders.
Type:
Grant
Filed:
September 27, 1984
Date of Patent:
August 6, 1985
Assignee:
Janssen Pharmaceutica
Inventors:
Ludo E. J. Kennis, Jan Vandenberk, Josephus C. Mertens
Abstract: Novel heterocyclic derivatives of (4-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles, useful as antifungal and antibacterial agents.
Abstract: Novel 5H-thiazolo- and 5H-1,3,4-thiadiazolo[3,2-a]-pyrimidin-5-one and 3,4-dihydro-2H,6H-pyrimido[2,1-b][1,3]-thiazin-6-one derivatives, which compounds are useful psychotropic agents.
Abstract: The invention is concerned with novel dithioketal derivatives of 1-(2-aryl-2-oxoethyl)-1H-imidazoles and sulfones and sulfoxides derived therefrom, said compounds being useful as antimicrobial agents.
Type:
Grant
Filed:
September 28, 1984
Date of Patent:
June 18, 1985
Assignee:
Janssen Pharmaceutica N.V.
Inventors:
Jan Heeres, Leo J. J. Backx, Joseph H. Mostmans
Abstract: Novel quinazoline derivatives, comprising in the heterocyclic part of their quinazoline nucleus at least one carbonyl or thiocarbonyl group and a particularly substituted piperidinyl-alkyl side chain, said compounds being potent serotonin-antagonists.
Type:
Grant
Filed:
March 26, 1982
Date of Patent:
June 11, 1985
Assignee:
Janssen Pharmaceutica N.V.
Inventors:
Jan Vandenberk, Ludo Kennis, Marcel Van der Aa, Albert Van Heertum
Abstract: Hybrid cell line for production of monoclonal antibody to an antigen found on all normal human helper T cells. The hybrid is formed by fusing splenocytes from immunized CAF.sub.1 mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.